Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 14-Sep-21 7:23 PM View:  | Formela Jean Francois Director | Translate Bio, Inc. (TBIO) | 14-Sep-21 | Market Sale (Planned) | 2,055,060 | $38.00 | $78,092,400.00 | (100%) 2.06M to 0 | 2% |
| 14-Sep-21 7:29 PM View: | Burgess Paul D. Chief Operating Officer, CLO | Translate Bio, Inc. (TBIO) | 14-Sep-21 | Market Sale | 71,833 | $38.00 | $2,729,650.00 | (100%) 71.83K to 0 | 2% |
| 14-Sep-21 9:59 AM View: | Sanofi-Aventis 10% Owner | Translate Bio, Inc. (TBIO) | 14-Sep-21 | Market Purchase | 71,983,600 | $38.00 | $2,735,379,968.00 | 1954% 3.68M to 75.67M | (2%) |
| 14-Sep-21 7:32 PM View: | Renaud Ronald C Jr Chief Executive Officer Director | Translate Bio, Inc. (TBIO) | 14-Sep-21 | Market Sale | 503,231 | $38.00 | $19,122,800.00 | (53%) 954.05K to 450.82K | 2% |
| 14-Sep-21 7:26 PM View: | Hughes Owen Director | Translate Bio, Inc. (TBIO) | 14-Sep-21 | Market Sale | 29,860 | $38.00 | $1,134,680.00 | (100%) 29.86K to 0 | 2% |
| 14-Sep-21 7:32 PM View: | Renaud Ronald C Jr Chief Executive Officer Director | Translate Bio, Inc. (TBIO) | 14-Sep-21 | Market Sale | 450,822 | $38.00 | $17,131,200.00 | (100%) 450.82K to 0 | 2% |
| 09-Apr-21 4:14 PM View: | Renaud Ronald C Jr Chief Executive Officer Director | Translate Bio, Inc. (TBIO) | 07-Apr-21 | Option Exercise | 9,026 | $7.39 | $66,702.10 | < 1% 945.12K to 954.14K | |
| 14-Jan-21 7:59 PM View: | Renaud Ronald C Jr Chief Executive Officer, Pres. Director | Translate Bio, Inc. (TBIO) | 14-Jan-21 | Option Exercise | 5,639 | $7.39 | $41,673.20 | < 1% 939.39K to 945.03K | |
| 23-Dec-20 6:07 PM View: | Formela Jean Francois Director | Translate Bio, Inc. (TBIO) | 22-Dec-20 | Market Sale (Planned) | 82,565 | $25.07 | $2,069,870.00 | (3%) 2.78M to 2.7M | 12% |
| 23-Dec-20 6:07 PM View: | Formela Jean Francois Director | Translate Bio, Inc. (TBIO) | 21-Dec-20 | Market Sale (Planned) | 56,536 | $25.50 | $1,441,930.00 | (2%) 2.84M to 2.78M | 13% |
| 16-Feb-21 10:00 PM View: | Lynch Daniel Director | Translate Bio, Inc. (TBIO) | 17-Dec-20 | Gift | 100,000 | -- | -- | (31%) 321.82K to 221.82K | |
| 18-Nov-20 7:30 PM View: | Renaud Ronald C Jr Chief Executive Officer, Pres. Director | Translate Bio, Inc. (TBIO) | 16-Nov-20 | Option Exercise | 53,007 | $7.39 | $391,725.00 | 6% 886.38K to 939.39K | |
| 27-Aug-20 8:14 PM View: | Formela Jean Francois Director | Translate Bio, Inc. (TBIO) | 27-Aug-20 | Market Sale | 10,097 | $14.38 | $145,217.00 | (< 1%) 3.84M to 3.83M | (54%) |
| 27-Aug-20 8:14 PM View: | Formela Jean Francois Director | Translate Bio, Inc. (TBIO) | 26-Aug-20 | Market Sale | 44,381 | $14.80 | $656,746.00 | (1%) 3.89M to 3.84M | (50%) |
| 27-Aug-20 8:14 PM View: | Formela Jean Francois Director | Translate Bio, Inc. (TBIO) | 25-Aug-20 | Market Sale | 34,410 | $15.00 | $516,160.00 | (< 1%) 3.92M to 3.89M | (48%) |
| 30-Jun-20 8:24 PM View: | Shire Human Genetic Therapi... 10% Owner | Translate Bio, Inc. (TBIO) | 30-Jun-20 | Private Sale | 6,824,990 | $20.68 | $141,140,992.00 | (100%) 6.82M to 0 | |
| 30-Jun-20 5:37 PM View: | Baupost Group Llc/ma 10% Owner | Translate Bio, Inc. (TBIO) | 26-Jun-20 | Market Purchase | 500,000 | $22.00 | $11,000,000.00 | 3% 17.54M to 18.04M | < 1% |
| 05-Jun-20 9:52 AM View: | Shire Human Genetic Therapi... 10% Owner | Translate Bio, Inc. (TBIO) | 03-Jun-20 | Market Sale | 40,086 | $19.75 | $791,698.00 | (< 1%) 6.87M to 6.82M | (12%) |
| 03-Jun-20 6:08 AM View: | Shire Human Genetic Therapi... 10% Owner | Translate Bio, Inc. (TBIO) | 02-Jun-20 | Market Sale | 105,395 | $19.76 | $2,082,900.00 | (2%) 6.97M to 6.87M | (12%) |
| 03-Jun-20 6:08 AM View: | Shire Human Genetic Therapi... 10% Owner | Translate Bio, Inc. (TBIO) | 01-Jun-20 | Market Sale | 108,472 | $19.86 | $2,154,120.00 | (2%) 7.08M to 6.97M | (11%) |
| 03-Jul-18 5:59 PM View: | Glaxosmithkline Plc 10% Owner | Translate Bio, Inc. (TBIO) | 02-Jul-18 | Conversion | 3,428,680 | -- | -- | 100% 0 to 3.43M | |
| 03-Jul-18 6:44 PM View: | Mrl Ventures Fund LLC 10% Owner | Translate Bio, Inc. (TBIO) | 02-Jul-18 | Conversion | 1,848,500 | -- | -- | 100% 0 to 1.85M | |
| 03-Jul-18 6:44 PM View: | Omega Fund Iv, L.P. 10% Owner | Translate Bio, Inc. (TBIO) | 02-Jul-18 | Conversion | 1,458,420 | -- | -- | 60% 2.44M to 3.9M | |
| 02-Jul-18 9:46 PM View: | Shire Human Genetic Therapi... 10% Owner | Translate Bio, Inc. (TBIO) | 02-Jul-18 | Acquisition (other) | 183,619 | -- | -- | 3% 6.9M to 7.08M | |
| 05-Jul-18 4:30 PM View: | Gallagher Brian M. Jr. Director | Translate Bio, Inc. (TBIO) | 02-Jul-18 | Purchase Duplicate | 269,230 | $13.00 | $3,499,990.00 | 8% 3.43M to 3.7M | |
| 03-Jul-18 6:37 PM View: | Formela Jean Francois Director | Translate Bio, Inc. (TBIO) | 02-Jul-18 | Conversion Duplicate | 3,832,010 | -- | -- | 4258% 90.0K to 3.92M | |
| 03-Jul-18 6:44 PM View: | Omega Fund Iv, L.P. 10% Owner | Translate Bio, Inc. (TBIO) | 02-Jul-18 | Conversion | 979,179 | -- | -- | 100% 0 to 979.18K | |
| 03-Jul-18 8:17 PM View: | Renaud Ronald C Jr See Remarks Director | Translate Bio, Inc. (TBIO) | 02-Jul-18 | Conversion | 81,818 | -- | -- | 22% 369.0K to 450.82K | |
| 03-Jul-18 5:59 PM View: | Glaxosmithkline Plc 10% Owner | Translate Bio, Inc. (TBIO) | 02-Jul-18 | Purchase | 269,230 | $13.00 | $3,499,990.00 | 8% 3.43M to 3.7M | |
| 03-Jul-18 6:43 PM View: | Atlas Venture Fund Viii, L.P. 10% Owner | Translate Bio, Inc. (TBIO) | 02-Jul-18 | Conversion | 3,832,010 | -- | -- | 4258% 90.0K to 3.92M | |
| 03-Jul-18 6:44 PM View: | Omega Fund Iv, L.P. 10% Owner | Translate Bio, Inc. (TBIO) | 02-Jul-18 | Conversion | 1,458,420 | -- | -- | 149% 979.18K to 2.44M | |
| 05-Jul-18 4:30 PM View: | Gallagher Brian M. Jr. Director | Translate Bio, Inc. (TBIO) | 02-Jul-18 | Conversion Duplicate | 3,428,680 | -- | -- | 100% 0 to 3.43M | |
| 03-Jul-18 6:44 PM View: | Mrl Ventures Fund LLC 10% Owner | Translate Bio, Inc. (TBIO) | 02-Jul-18 | Purchase | 25,000 | $13.00 | $325,000.00 | 1% 1.85M to 1.87M |
